52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
NCT06689085
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypogonadism, Male
Interventions
COMBINATION_PRODUCT:
Testosterone enanthate
Sponsor
Halozyme Therapeutics